November 25, 2021
Pushkara Ali Paka
(Reuters)-EU drug regulators approved Pfizer-BioNTech’s COVID-19 vaccine for children ages 5 to 11 on Thursday, causing infections in Europe.
The European Medicines Agency (EMA) has given Pfizer BioNTech vaccine approved for use in the European Union to teens aged 12 to 17 years since May at a dose of 10 micrograms twice at 3-week intervals. Recommended to inject into. The adult dose contains 30 micrograms.
Approval is obtained as Europe is once again the epicenter of the pandemic and https://reut.rs/32yJp0j, which accounts for about half of the cases and deaths.
Inoculating children and adolescents who can unknowingly infect others with COVID-19 is considered an important step in controlling the pandemic. In Germany and the Netherlands, children now make up the majority of cases.
Pfizer and BioNTech say a vaccine called Comirnaty was 90.7% effective against coronavirus in clinical trials in children aged 5 to 11 years.
“The benefits of Comirnaty in children aged 5 to 11 outweigh the risks, especially in children with an increased risk of severe COVID-19,” EMA said at https://www.ema.europa.eu/. I mentioned en / news /. comirnaty-covid-19-vaccine-ema-recommends-approval-children-aged-5-11.
Final approval is up to the European Commission, but usually following EMA recommendations, EU sources have told Reuters that a decision is likely to be made on Friday.
“Today’s recommendation (…) is clear that the BioNTech-Pfizer vaccine is safe and effective for young children and can provide them with additional protection,” EU Health Commissioner Stella Kiriyakides said on Twitter. I did.
Countries will not be able to start deploying shots among young children until next month. The first low-dose pediatric version will be available on December 20, according to a BioNTech spokeswoman.
Wojciech Andrusiewicz, a spokesman for the Polish Ministry of Health, told state news agency PAP that Poland will begin vaccination of children aged 5 to 11 years in December.
The EU participates in countries that are vaccinated for children under the age of 5-11, such as the United States, Canada, Israel, China and Saudi Arabia https://reut.rs/3COxM1t.
Tens of millions of children in this age group are eligible for shots in the EU. A BioNTech spokeswoman said Germany would inoculate 2.4 million doses on its first shipment, enough to inoculate about half of children aged 5 to 11 years.
For pediatric shots, US regulatory authorities have approved a new version of the vaccine. It uses a new buffer and allows it to be stored in the refrigerator for up to 10 weeks.
The surge in Europe is a new stumbling block as winter dominates the region, people gather indoors for Christmas celebrations and provide optimal conditions for COVID-19 to spread. Promoted popular suppression https://reut.rs/3nPYov1.
Slovakia launched a two-week lockdown on Thursday https://www.reuters.com/world/europe/europe-rethinks-booster-shot-policy-covid-cases-hit-records-2021-11-24 While the Austrian, Portuguese and French governments are considering more restrictions.
Health experts have promoted widespread use of booster shots to avoid overwhelming hospitals as immunity from previous shots weakens, but vaccination of young people is to fight the virus. Another tool.
However, some countries have restricted young people to use COVID-19 shots based on the so-called mRNA technology used by Pfizer BioNTech after reports of possible rare cardiovascular side effects. ..
Anthony Fauci, a top US infectious disease official, said Reuters hasn’t had any signs of new safety issues this week since the launch of vaccines for young children began earlier this month.
At least 10% of the 28 million eligible US children receive a first dose.
(Report by Pushkala Aripaka in Bangalore, Francesco Guarascio in Brussels, Patricia Weiss in Frankfurt, Additional report by Alan Charlish in Warsaw, Written by Josephine Mason, Edited by Alexander Smith)
EU regulators take the initiative on the first COVID shot aged 5-11
Source link EU regulators take the initiative on the first COVID shot aged 5-11